§ 21-216. Adulterated drugs and devices

§ 21-217. Misbranded drugs and devices -- In general

§ 21-218. Additional grounds of drug misbranding

§ 21-219. Exemptions from labeling and packaging requirements for drugs and devices subject to additional processing, labeling, or packing

§ 21-220. Prescription requirements

§ 21-221. Label requirements for prescription drugs; exemption from provisions on misbranded drugs

§ 21-222. Construction of §§ 21-220 and 21-221

§ 21-223. New drugs -- In general

§ 21-224. New drugs -- Exemption when intended for investigational use only

§ 21-225. New drugs -- Inspection of records

§ 21-226. Printed information for use of practitioners

§ 21-227. Provision of information on request of Secretary

§ 21-228, 21-229.